In 2015 the US Food and Drug Administration (“FDA”) issued guidance on how to conduct shedding studies during the preclinical and clinical development of virus or bacteria-based gene therapy products. Shedding, as described by the FDA, is the excretion or release of a product from a vaccinated person’s body.
The shed gene therapy product may be infectious and so raises safety concerns “related to the risk of transmission to untreated individuals.” Various studies and documents, including a study by Pfizer, indicate vaccine shedding and transmission are occurring. Would you trust anything that’s shed from a Covid injection as good for you or anyone around you?
A University of Colorado study published in May provided evidence “for a new mechanism by which herd immunity may be manifested – the aerosol transfer of antibodies between immune and non-immune hosts.” Consistent with the results reported by others, the researchers detected antibodies in both vaccinated people’s saliva and their face masks. “Given these observations, we hypothesised that droplet/aerosolised antibody transfer might occur between individuals, much like droplet/aerosolised virus particles can be exchanged by the same route.”